News
Important Only
Itau, Santander, Citi strike deals to end Brazil tax disputes
By Marcela Ayres and Bernardo CaramBRASILIA, Feb 4 (Reuters) - Brazil's National Treasury Attorney General's Office (PGFN) has reached settlement deals with lenders Itau ITUB3.SA, Santander Brasil SANB3.SA and Citi that resulted in about 2.4 billion reais ($458.13 million) in tax payments in...Reuters
Wed, Feb 4
Washington Post to lay off hundreds of journalists, NYT reports
Feb 4 (Reuters) - The Washington Post plans to lay off hundreds of journalists, the New York Times reported on Wednesday, citing a video call with employees. This move comes days after the newspaper scaled back its coverage of the 2026 Winter Olympics amid mounting financial losses.Reuters
Wed, Feb 4
GRI Bio raises $14.5 mln to fund operations into Q1 2027
OverviewBiotechnology company raised $14.5 mln in gross proceeds to fund operations into Q1 2027Company announced positive Phase 2a data for GRI-0621 in idiopathic pulmonary fibrosisCash position expected to fund operations into Q1 2027OutlookCompany expects cash to fund operations into Q1 2027GRI B...Reuters
Wed, Feb 4
Oncolytics Biotech® Receives FDA Fast Track Designation For Pelareorep In 2L Kras-Mutant Mss Metastatic Colorectal Cancer
Feb 4 (Reuters) - Oncolytics Biotech Inc ONCY.O:ONCOLYTICS BIOTECH® RECEIVES FDA FAST TRACK DESIGNATION FOR PELAREOREP IN 2L KRAS-MUTANT MSS METASTATIC COLORECTAL CANCERONCOLYTICS BIOTECH INC - TO LAUNCH CONTROLLED STUDY IN SECOND-LINE KRAS-MUTANT MSS MCRC WITH INTERIM DATA EXPECTED BY END OF 2026Reuters
Wed, Feb 4
CORRECTED-Johnson Controls beats Q1 EPS estimates; ups FY profit view
OverviewIreland-based energy solutions provider's Q1 sales rose 7% but missed analyst expectationsAdjusted EPS of $0.89 for Q1 beat analyst expectationsCompany raised FY26 adjusted EPS guidance to $4.70 from $4.55OutlookJohnson Controls raises FY26 adjusted EPS guidance to $4.70 from $4.55Compan...Reuters
Wed, Feb 4
REFILE-CDW beats fourth-quarter estimates on resilient demand for IT solutions
Feb 4 (Reuters) - CDW CDW.O beat fourth-quarter sales and profit estimates on Wednesday, as clients continue to invest in artificial intelligence and cloud adoption.Shares of the Vernon Hills, Illinois-based company rose 5.8% in premarket trading. The IT solutions provider has benefited from demand ...Reuters
Wed, Feb 4
Golden Sun Technology Group Ltd - Changed Corporate Name From “Golden Sun Health Technology Group Limited” To “Golden Sun Technology Group Limited”
Feb 4 (Reuters) - Golden Sun Technology Group Ltd GSUN.O:GOLDEN SUN TECHNOLOGY GROUP LTD - CHANGED CORPORATE NAME FROM “GOLDEN SUN HEALTH TECHNOLOGY GROUP LIMITED” TO “GOLDEN SUN TECHNOLOGY GROUP LIMITED”GOLDEN SUN TECHNOLOGY GROUP LTD - COMPANY’S CLASS A ORDINARY SHARES WILL BE TRADED UNDER THE NEW...Reuters
Wed, Feb 4
Lawmakers urge Trump to drop proposal to slash vehicle fuel economy rules
Proposed rule might cut upfront vehicle costs by $930 but raise long-term fuel expensesEx-president Biden's rules encouraged EV production without ending gas vehicles immediatelyNHTSA plans to revise heavy-duty trucks and passenger vans standards tooBy David Shepardson WASHINGTON, Feb 4 (Reut...Reuters
Wed, Feb 4
PRESS DIGEST-Canada - February 4
Feb 4 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.THE GLOBE AND MAILCanada Enterprise Emergency Funding Corporation (CEEFC) has named the career risk-management professional Lorraine Aud...Reuters
Wed, Feb 4
Core AI Plans Partnership With Premier Data Center Developer To Speed AI Infrastructure Expansion In Malaysia
Feb 4 (Reuters) - Core AI Holdings Inc CHAI.O:CORE AI ANNOUNCES PLANNED PARTNERSHIP WITH PREMIER DATA CENTER DEVELOPER TO ACCELERATE AI INFRASTRUCTURE EXPANSION IN MALAYSIACORE AI HOLDINGS INC - COLLABORATION AIMS FOR OPERATIONAL READINESS IN 12 MONTHSReuters
Wed, Feb 4
Nasdaq proposes "fast entry" rule to speed up inclusion of large new listings
Feb 4 (Reuters) - Nasdaq NDAQ.O has proposed a new rule to speed up the addition of newly listed large companies to its index, seeking to address delays that have left major IPOs and exchange transfers outside the benchmark for months.The proposal comes as 2026 is shaping up to be one of the busiest...Reuters
Wed, Feb 4
Coherus Oncology Inc - Announces Agreement With Janssen - SEC Filing
Feb 4 (Reuters) - Coherus Oncology Inc CHRS.O:COHERUS ONCOLOGY INC - ANNOUNCES AGREEMENT WITH JANSSEN - SEC FILINGCOHERUS ONCOLOGY INC: JANSSEN WILL PROVIDE PASRITAMIG TO COMPANY, WHO WILL BE SPONSOR OF PHASE 1B CLINICAL TRIALCOHERUS ONCOLOGY INC - JANSSEN AND CO EACH RETAIN ALL COMMERCIAL RIGHTS TO...Reuters
Wed, Feb 4
Osmo, Digital Scent Design Company, Announces $70M In Series B Funding
Feb 4 (Reuters) - OSMO, DIGITAL SCENT DESIGN COMPANY, ANNOUNCES $70M IN SERIES B FUNDINGOSMO:ROUND LED BY TWO SIGMA VENTURES,PARTICIPATION FROM NEW INVESTORS INCLUDING VALOR, ATREIDES, AMPLO, ALUMNI VENTURES, COLLAB FUND, LUMINA PARTNERSFurther company coverage: [ ]Reuters
Wed, Feb 4
Biodexa Announces Exclusive License Of Otsuka’S Opb-171775, A Potent Phase 1 Ready Molecular Glue For Gist
Feb 4 (Reuters) - Biodexa Pharmaceuticals PLC 5MPy.F:BIODEXA ANNOUNCES EXCLUSIVE LICENSE OF OTSUKA’S OPB-171775, A POTENT PHASE 1 READY MOLECULAR GLUE FOR GISTFurther company coverage: [5MPy.F]Reuters
Wed, Feb 4
Clps Incorporation Announces Share Repurchase Program Of Up To 1,000,000 Shares
Feb 4 (Reuters) - CLPS Inc CLPS.O:CLPS INCORPORATION ANNOUNCES SHARE REPURCHASE PROGRAM OF UP TO 1,000,000 SHARESCLPS INC: REPURCHASE PROGRAM IS SCHEDULED TO COMMENCE ON FEBRUARY 5, 2026, AND WILL CONCLUDE ON NOVEMBER 4, 2026Reuters
Wed, Feb 4
Willis Lease Finance Corporation Signs Constantthrust® Agreement With Asia Pacific Flag Carrier, Nauru Airlines
Feb 4 (Reuters) - Willis Lease Finance Corp WLFC.O:WILLIS LEASE FINANCE CORPORATION SIGNS CONSTANTTHRUST® AGREEMENT WITH ASIA PACIFIC FLAG CARRIER, NAURU AIRLINESWILLIS LEASE FINANCE CORP - DEAL TERMS ARE EXTENDABLE TO ACCOMMODATE NEW AIRCRAFT DELIVERIESReuters
Wed, Feb 4
Sarepta Therapeutics Announces Clinical Trial Application Approval For SRP-1005 In Huntington’s Disease
Feb 4 (Reuters) - Sarepta Therapeutics Inc SRPT.O:SAREPTA THERAPEUTICS ANNOUNCES APPROVAL OF CLINICAL TRIAL APPLICATION FOR SRP-1005, ITS INVESTIGATIONAL TREATMENT FOR HUNTINGTON’S DISEASESAREPTA THERAPEUTICS INC - FIRST-IN-HUMAN CLINICAL STUDY OF SRP-1005, KNOWN AS INSIGHTT, IS EXPECTED TO BEGIN IN...Reuters
Wed, Feb 4
